|
|
Profile
|
Delegates :
Robert M Hoffman, PhD |
|
Incorporated :
November 6 , 2006 |
Paid in Capital :
1 Million yen |
Employees :
3 人 |
Address :
2-23-5 Ryukakujidai, Sakae town, Inba-gun Chiba Japan CHIBA
〒270-1505
|
TEL/FAX :
+81-476-77-8555 / +81-476-77-8015 |
URL：
http://www.anticancerjapan.com |
Attachment :
|
Mission/Background :
AntiCancer Inc. of San Diego, CA, the parent company, was established at Nov. 1984 by Dr. RobertM Hoffman of UCSD.
AntiCancer Japan Inc. was established as a subsidiary of AntiCancer Inc. at Nov. 2006.
AntiCancer Japan is located at Saito, Osaka. |
|
Technology & Business
|
AntiCancer is the only one company who has in vivo mouse model pf cancer growth and metastable using GFP/RFP cancer cells. More than 80 kinds of GFP/RFP cancer Cells are available from Wako Pure Chem. and contract research services are available using above technology from AntiCancer Japan.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
GFP/RFP cancer cells
|
Launched
|
These products are available from Wako Pure Chem.
|
To increase sales of GFP/RFP cancer cells
|
Contract research using flourescent protein cancer cells
|
Service/Marketing
|
We will evaluate the drug efficacy for anticancer drug using GFP/RFP cancer cells and mouse model.
|
|
GFP/RFP/CFP nude mice
|
Launched
|
GFP transgenic mice are available from Nippon SLC
|
|
Whole body imaging system
|
Launched
|
Whole body fluorescence imaging systems are available from Molecular Devices
|
|
PDX and PDOX cancer mouse creation
|
Launched
|
Drug evaluation using PDOX mouse
|
|
|
Highlights
|
Collaborative research with Osaka University are published.
Other collaborative/contract research with various public institutes and private sectors are on
progress.
|
|
Hot news
|
Revised version of catalog including our GFP/RFP cancer cells together with available services will be issued and this new catalog will be delivered during show.
|
|
Alliance strategy
|
Together with GFP/RFP cancer cells, we are focusing to increase the contract research servises using our technologies with public institutes and private sectors.
|
|
|